{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Peak Daily","title":"Cancer killer 🧪 — Montreal-based Repare Therapeutics has a new deal for their cancer drug. Canadian investors aren’t happy with disclosure from their green investments. And Canadians are losing their buying power.","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/b25f46b4\"></iframe>","width":"100%","height":180,"duration":563,"description":"Montreal-based Repare Therapeutics has entered a deal (potentially worth US$1.2 billion) with pharma giant F Hoffman La Roche to create a new drug to treat cancerous tumours.\n\nAlmost half of Canada’s asset managers, researchers and lenders are “not very satisfied” or “totally dissatisfied” with available company data for so-called “green” investments,\n\nOne estimate suggests that inflation has offset two-thirds of the buying power of Canadians after the pandemic\n\nThe Peak Daily is produced by 306 Media Productions. Hosted by Brett Chang and Jay Rosenthal.","thumbnail_url":"https://img.transistorcdn.com/mOKuLVp8ENXizw8pFS5GUywt3l9MDz3H769LJwNxws4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iZGI4/ODAwMzI2MzdjZjQy/YzBlNGU0OTA1MTky/MjExNC5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}